MedPAC > Our Work > Drugs, Devices, and Tests > MedPAC comment on CMS’s notice of proposed rulemaking on contract year 2023 policy and technical changes to Medicare Advantage and Part D
MedPAC comment on CMS’s notice of proposed rulemaking on contract year 2023 policy and technical changes to Medicare Advantage and Part D